Rezultati pretraživanja
  1. prije 5 sati

    enters a Downtrend as Momentum Indicator dropped below the 0 level on January 21, 2020. View odds for this and other indicators:

  2. 5. velj

    Rubius Therapeutics Lifted to “Hold” at BidaskClub

  3. 4. velj

    Stocks trades: Value entered , Genetics exited . I benched these positions: Growth , Momentum , Robotics .

  4. 4. velj

    : New Insider Filing on Chief Financial Officer ANDREW M. OH:

  5. 3. velj

    In stocks, I've changed my stop/loss model. No exits this morning. I entered three positions in the Genetics Portfolio: .

  6. 3. velj

    Rubius Therapeutics Inc Receives Consensus Rating of “Buy” from Analysts

  7. 2. velj

    Rubius Therapeutics Raised to “Buy” at Zacks Investment Research

  8. 30. sij

    Baird Even with the trial start, we remain critical of RUBY’s RCT platform, particularly with the lack of visibility on timing for clinical data from this study. We thus reiterate our RUBY Underperform rating, $3 price target, and RUBY’s status as a bearish Fresh Pick.

  9. 30. sij

    Congrats to Rubius for actually dosing a patient finally

  10. 30. sij

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.